4-boronophenylalanine has been researched along with Head and Neck Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collette, L; Moss, R; Sauerwein, WA; Wittig, A | 1 |
| Barth, RF; Binns, P; Riley, K; Tjarks, W; Wu, G; Yang, W | 1 |
| Appelman, K; Bührmann, S; Collette, L; Jäckel, MC; Jöckel, KH; Moss, R; Ortmann, U; Sauerwein, WAG; Schmid, KW; Wittig, A | 1 |
| Basilico, F; Bendel, P; Mauri, PL; Sauerwein, W; Wittig, A | 1 |
| Chou, FI; Chung, HP; Lin, YC; Liu, HM; Wang, SJ | 1 |
| Chen, YW; Kashino, G; Kirihata, M; Liu, Y; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
2 trial(s) available for 4-boronophenylalanine and Head and Neck Neoplasms
| Article | Year |
|---|---|
Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
Topics: Adenocarcinoma; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Colorectal Neoplasms; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Male; Neoplasms; Phenylalanine; Prospective Studies; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Thyroid Neoplasms; Tissue Distribution | 2009 |
EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial.
Topics: Adult; Aged; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phenylalanine; Sulfhydryl Compounds; Tissue Distribution | 2009 |
4 other study(ies) available for 4-boronophenylalanine and Head and Neck Neoplasms
| Article | Year |
|---|---|
Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
Topics: Animals; Antibodies, Monoclonal; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; ErbB Receptors; Glioma; Head and Neck Neoplasms; Humans; Phenylalanine; Radiation-Sensitizing Agents; Radiometry; Rats; Rats, Inbred F344 | 2009 |
Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients--results from EORTC trial 11001.
Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Clinical Trials as Topic; Fructose; Head and Neck Neoplasms; Humans; Magnetic Resonance Spectroscopy; Phenylalanine; Sulfhydryl Compounds; Time Factors | 2010 |
Low dose of gamma irradiation enhanced boronophenylalanine uptake in head and neck carcinoma cells for boron neutron capture therapy.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Radiation; G2 Phase; Gamma Rays; Head and Neck Neoplasms; Phenylalanine | 2011 |
Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Drug Interactions; Female; Head and Neck Neoplasms; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Phenylalanine; Radiation-Sensitizing Agents; Tissue Distribution; Treatment Outcome | 2013 |